These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 32410959)
21. Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain. Yuill MB; Hale DE; Guindon J; Morgan DJ Mol Pain; 2017; 13():1744806917728227. PubMed ID: 28879802 [TBL] [Abstract][Full Text] [Related]
22. OCP002, a Mixed Agonist of Opioid and Cannabinoid Receptors, Produces Potent Antinociception With Minimized Side Effects. Xu B; Zhang Q; Chen D; Zhang M; Zhang R; Zhao W; Qiu Y; Xu K; Xiao J; Niu J; Shi Y; Li N; Fang Q Anesth Analg; 2023 Feb; 136(2):373-386. PubMed ID: 36638515 [TBL] [Abstract][Full Text] [Related]
23. Improved efficacy, tolerance, safety, and abuse liability profile of the combination of CR4056 and morphine over morphine alone in rodent models. Sala E; Ferrari F; Lanza M; Milia C; Sabatini C; Bonazzi A; Comi E; Borsi Franchini M; Caselli G; Rovati LC Br J Pharmacol; 2020 Jul; 177(14):3291-3308. PubMed ID: 32154915 [TBL] [Abstract][Full Text] [Related]
24. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice. Shen KF; Crain SM Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746 [TBL] [Abstract][Full Text] [Related]
25. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958 [TBL] [Abstract][Full Text] [Related]
26. Median Nerve Stimulation as a Nonpharmacological Approach to Bypass Analgesic Tolerance to Morphine: A Proof-of-Concept Study in Mice. Lee MT; Chen YH; Mackie K; Chiou LC J Pain; 2021 Mar; 22(3):300-312. PubMed ID: 33069869 [TBL] [Abstract][Full Text] [Related]
27. Morphine-induced antinociception and reward in "humanized" mice expressing the mu opioid receptor A118G polymorphism. Henderson-Redmond AN; Yuill MB; Lowe TE; Kline AM; Zee ML; Guindon J; Morgan DJ Brain Res Bull; 2016 May; 123():5-12. PubMed ID: 26521067 [TBL] [Abstract][Full Text] [Related]
28. Slowly Signaling G Protein-Biased CB Lin X; Dhopeshwarkar AS; Huibregtse M; Mackie K; Hohmann AG Mol Pharmacol; 2018 Feb; 93(2):49-62. PubMed ID: 29192123 [TBL] [Abstract][Full Text] [Related]
29. Effects of Cannabinoid Type 2 Receptor Agonist AM1241 on Morphine-Induced Antinociception, Acute and Chronic Tolerance, and Dependence in Mice. Zhang M; Dong L; Zou H; Li J; Li Q; Wang G; Li H J Pain; 2018 Oct; 19(10):1113-1129. PubMed ID: 29729431 [TBL] [Abstract][Full Text] [Related]
30. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores. Lenard NR; Daniels DJ; Portoghese PS; Roerig SC Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633 [TBL] [Abstract][Full Text] [Related]
31. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice. Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809 [TBL] [Abstract][Full Text] [Related]
32. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance. Trang T; Sutak M; Jhamandas K Neuroscience; 2007 May; 146(3):1275-88. PubMed ID: 17395382 [TBL] [Abstract][Full Text] [Related]
33. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence. Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913 [TBL] [Abstract][Full Text] [Related]
34. Experimental Colitis Enhances the Rate of Antinociceptive Tolerance to Morphine via Peripheral Opioid Receptors. Komla E; Stevens DL; Zheng Y; Zhang Y; Dewey WL; Akbarali HI J Pharmacol Exp Ther; 2019 Sep; 370(3):504-513. PubMed ID: 31248978 [TBL] [Abstract][Full Text] [Related]
35. Daily intermittent fasting in mice enhances morphine-induced antinociception while mitigating reward, tolerance, and constipation. Duron DI; Hanak F; Streicher JM Pain; 2020 Oct; 161(10):2353-2363. PubMed ID: 32427747 [TBL] [Abstract][Full Text] [Related]